Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02355938 · ClinicalTrials.gov registry record · Phase 4
Use Of Oral Fidaxomicin Vs. Oral Vancomycin For Clostridium Difficile Infection In Patients With Spinal Cord Injury
A Phase 4 study, sponsored by Baylor College of Medicine.
- Terminated
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT02355938 is a Phase 4 study that was terminated before completion, run by Baylor College of Medicine. The registered enrollment target is 12 participants.
The verdict
NCT02355938, a Phase 4 study, was terminated before completion, sponsored by Baylor College of Medicine.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
The primary purpose of this study is to compare the clinical outcomes of cure and recurrence of Clostridium difficile infection in spinal cord injured patients who are treated with oral Fidaxomicin vs. oral Vancomycin. The secondary aim of this study is to compare the overall costs of treatment of Clostridium difficile infection in the two study groups.
Interventions
- DRUG Placebo
- DRUG Vancomycin
- DRUG Fidaxomicin 200 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02355938
The ClinicalTrials.gov registry entry for NCT02355938 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02355938 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02355938 about?
NCT02355938 is a clinical study titled "Use Of Oral Fidaxomicin Vs. Oral Vancomycin For Clostridium Difficile Infection In Patients With Spinal Cord Injury". The primary purpose of this study is to compare the clinical outcomes of cure and recurrence of Clostridium difficile infection in spinal cord injured patients who are treated with oral Fidaxomicin vs. oral Vancomycin. The secondary aim of this study is to compare the overall costs of treatment of C...
What is the current status of trial NCT02355938?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2014-02. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02355938?
The interventions under investigation include: Placebo (DRUG), Vancomycin (DRUG), Fidaxomicin 200 mg (DRUG).
Who is sponsoring clinical trial NCT02355938?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.